Hydralazine HCl | 1-肼苯哒嗪盐酸盐 | Hydralazine (hydrochloride) | Antihypertensive Agent

首页 / 抑制剂/激动剂 / 膜转运蛋白 / 钾通道 / Hydralazine HCl

盐酸肼屈嗪 /Hydralazine HCl {[allProObj[0].p_purity_real_show]}

货号：A256420 同义名： 1-肼苯哒嗪盐酸盐 / Hydralazine (hydrochloride);1-Hydrazinophthalazine

Hydralazine HCl is a direct-acting vasodilator that is used as an antihypertensive agent.

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Hydralazine HCl 化学结构
CAS号：304-20-1

Hydralazine HCl 3D分子结构
CAS号：304-20-1

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Hydralazine HCl 纯度/质量文件产品仅供科研

货号：A256420 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • JACS Au, 2024. Ambeed. [ A148168 ]; • JMC, 2024. Ambeed. [ A187643 ]; • JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]; • Biomacromolecules, 2024. Ambeed. [ A110759 ]; • Biomacromolecules, 2024. Ambeed. [ A203543 ]; 更多 >

钾通道亚型比较

产品名称	Potassium Channel ↓ ↑	纯度
Tolbutamide	✔	{[allProObj[0].p_purity_real_show]}
Glimepiride	++++ SUR2B, IC50: 7.3 nM SUR1, IC50: 5.4 nM	{[allProObj[0].p_purity_real_show]}
Dronedarone Hydrochloride	✔	{[allProObj[0].p_purity_real_show]}
Gliquidone	++ Potassium channel, IC50: 27.2 nM	{[allProObj[0].p_purity_real_show]}
TRAM-34	+++ IKCa1 (KCa3.1), Kd: 20 nM	{[allProObj[0].p_purity_real_show]}
Glibenclamide	✔	{[allProObj[0].p_purity_real_show]}
Amiodarone HCl	✔	{[allProObj[0].p_purity_real_show]}
Gliclazide	++ Potassium channel, IC50: 184 nM	{[allProObj[0].p_purity_real_show]}
Repaglinide	✔	{[allProObj[0].p_purity_real_show]}
Dofetilide	✔	{[allProObj[0].p_purity_real_show]}
Nateglinide	✔	{[allProObj[0].p_purity_real_show]}
Quinine hydrochloride dihydrate	✔	{[allProObj[0].p_purity_real_show]}
ML133 HCl	+ Kir2.1, IC50: 290 nM	{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Hydralazine HCl 生物活性

描述

Hydralazine hydrochloride (HHC) is a direct-acting smooth muscle relaxant used to treat hypertension by acting as a vasodilator primarily in arteries and arterioles. The preliminary IV administration of dihydralazine allowed a reduced volatile agent concentration which attenuated undesirable haemodynamic effects, in spite of renin and norepinephrine release, and permitted a rapid intraoperative awakening^[3]. Hydralazine hydrochloride may reduce blood pressure when compared to placebo in patients with primary hypertension, however this data is based on before and after studies, not RCTs (randomized controlled trials)^[4]. The suitability of the prepared HHC sublingual tablets for use in rapid control on hypertensive crisis especially in pregnant women as an alternate to parenteral administration^[5]. The combination consists of 20 mg of isosorbide and 37.5 mg hydralazine hydrochloride in a fixed dose that functions as a nitric oxide enhancer and an antioxidant, and helps to prevent tolerance to the prolonged use of nitrate^[6].

Hydralazine HCl 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT02884011	-		Completed	-	United States, Illinois ... 展开 >> Rush Univeristy Medical Center Chicago, Illinois, United States, 60612 收起 <<
NCT03608085	Heart Failure	Not Applicable	Recruiting	May 31, 2019	United States, Rhode Island ... 展开 >> Ocean State Research Institute Recruiting Providence, Rhode Island, United States, 02908 Contact: Mary Ford 401-273-7100 ext 3674 Mary.Ford@va.gov Principal Investigator: Tracey H Taveira, Pharm.D. Sub-Investigator: Philip Haines, MD Sub-Investigator: Wen-Chih Wu, MD Providence VAMC Recruiting Providence, Rhode Island, United States, 02908 Contact: Melanie R Parent, Ba 401-273-7100 ext 6293 Melanie.Parent@va.gov Principal Investigator: Tracey H Taveira, Pharm.D. 收起 <<
NCT03619317	-		Recruiting	August 2020	Denmark ... 展开 >> University Hospital of Aarhus, Department of Cardiology Recruiting Aarhus N, Denmark, 8200 Contact: Mette Søndergaard 30130565 metast@rm.dk Contact: Steen Poulsen steen.hvitfeldt@rm.dk 收起 <<

Hydralazine HCl 参考文献

[1]Mazari L, Ouarzane M, et al. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6317-22. Epub 2007 Apr 2.

[2]Burcham PC, Pyke SM. Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Mol Pharmacol. 2006 Mar;69(3):1056-65.

[3]Bourreli B, Pinaud M, Passuti N, Gunst JP, Drouet JC, Remi JP. Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion. Can J Anaesth. 1988;35(3 ( Pt 1)):242-248

[4]Kandler MR, Mah GT, Tejani AM, Stabler SN. Hydralazine for essential hypertension. Cochrane Database Syst Rev. 2010;(8):CD004934. Published 2010 Aug 4

[5]Genedy S, Khames A, Hussein A, Sarhan H. Hydralazine HCl rapidly disintegrating sublingual tablets: simple dosage form of higher bioavailability and enhanced clinical efficacy for potential rapid control on hypertensive preeclampsia. Drug Des Devel Ther. 2018;12:3753-3766. Published 2018 Nov 5

[6]Ferdinand KC. Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety. Expert Rev Cardiovasc Ther. 2005;3(6):993-1001

Hydralazine HCl 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

5.09mL

1.02mL

0.51mL

25.43mL

5.09mL

2.54mL

50.86mL

10.17mL

5.09mL

Hydralazine HCl 技术信息

CAS号	304-20-1
分子式	C₈H₉ClN₄
分子量	196.637

别名	1-肼苯哒嗪盐酸盐 ;Hydralazine (hydrochloride);1-Hydrazinophthalazine;Nepresol;mono-Hydrochloride, Hydralazine;Hydralazine chloride;Apresoline;Aiselazine;1-Hydrazinophthalazine hydrochloride;Hydralazine hydrochloride
运输	蓝冰

存储条件

粉末 Inert atmosphere,Room Temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 25 mg/mL(127.14 mM)，配合低频超声，并调节pH至11，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

H₂O: 25 mg/mL(127.14 mM)，配合低频超声助溶

动物实验配方

PO 0.5% CMC-Na 31 mg/mL suspension

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT02884011	-		Completed	-	United States, Illinois ... 展开 >> Rush Univeristy Medical Center Chicago, Illinois, United States, 60612 收起 <<
NCT03608085	Heart Failure	Not Applicable	Recruiting	May 31, 2019	United States, Rhode Island ... 展开 >> Ocean State Research Institute Recruiting Providence, Rhode Island, United States, 02908 Contact: Mary Ford 401-273-7100 ext 3674 Mary.Ford@va.gov Principal Investigator: Tracey H Taveira, Pharm.D. Sub-Investigator: Philip Haines, MD Sub-Investigator: Wen-Chih Wu, MD Providence VAMC Recruiting Providence, Rhode Island, United States, 02908 Contact: Melanie R Parent, Ba 401-273-7100 ext 6293 Melanie.Parent@va.gov Principal Investigator: Tracey H Taveira, Pharm.D. 收起 <<
NCT03619317	-		Recruiting	August 2020	Denmark ... 展开 >> University Hospital of Aarhus, Department of Cardiology Recruiting Aarhus N, Denmark, 8200 Contact: Mette Søndergaard 30130565 metast@rm.dk Contact: Steen Poulsen steen.hvitfeldt@rm.dk 收起 <<
NCT00683696	-		Terminated	-	-
NCT00683696	Heart Failure ... 展开 >> Ventricular Dyssynchrony 收起 <<	Phase 2 Phase 3	Terminated	-	-
NCT00283686	Kidney, Polycystic	Phase 3	Completed	-	United States, Colorado ... 展开 >> University of Colorado Health Sciences Center Denver (Aurora), Colorado, United States, 800045 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Tufts University-New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 收起 <<
NCT00000620	-		Completed	-	-
NCT00000620	Atherosclerosis ... 展开 >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease 收起 <<	Phase 3	Completed	-	United States, Minnesota ... 展开 >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada 收起 <<
NCT01958801	Horner's Syndrome	Not Applicable	Completed	-	Korea, Republic of ... 展开 >> Daegu Catholic University Medical Center Daegu, Korea, Republic of, 705-718 收起 <<
NCT00582777	Hypertensive Renal Disease	Phase 2 Phase 3	Completed	-	United States, Alabama ... 展开 >> University of Alabama Birmingham, Alabama, United States, 35233 United States, California University of Southern California Los Angeles, California, United States, 90033 Charles Drew Medical College Los Angeles, California, United States, 90059 University of California at San Diego San Diego, California, United States, 92161 United States, Florida University of Florida Gainesville, Florida, United States, 32611 University of Miami Miami, Florida, United States, 33101 United States, Georgia Emory University Atlanta, Georgia, United States, 30308 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48106 United States, New York Lenox Hill Hospital New York, New York, United States, 10021 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Ohio State University Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas Univesity of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 收起 <<
NCT00661895	-		Completed	-	-
NCT00226096	CVA (Cerebrovascular Accident)... 展开 >> Cerebral Hemorrhage Intracranial Hemorrhages 收起 <<	Not Applicable	Completed	-	Australia, New South Wales ... 展开 >> Concord Hospital Concord, New South Wales, Australia, 2138 Gosford Hospital Gosford, New South Wales, Australia, 2250 St George Hospital Kogarah, New South Wales, Australia, 2217 John Hunter Hospital Newcastle, New South Wales, Australia, 2310 St Vincent's Hospital Sydney, New South Wales, Australia, 2010 Royal Prince Alfred Hospital Sydney, New South Wales, Australia, 2050 Westmead Hospital Westmead, New South Wales, Australia, 2145 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 St Vincent's Hospital Melbourne, Victoria, Australia, 3065 Box Hill Hospital Melbourne, Victoria, Australia, 3128 Alfred Hospital Melbourne, Victoria, Australia, 3181 Austin Health Melbourne, Victoria, Australia Monash Medical Centre Melbourne, Victoria, Australia Australia, Western Australia Sir Charles Gairdner Hospital Perth, Western Australia, Australia, 6009 China Regional Coordinating Centre: Peking University First Hospital Beijing, China, 100034 Hospitals in China, c/o The George Institute China Beijing, China Regional Coordinating Centre: Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Second Medical University Shanghai, China, 200025 New Zealand North Shore Hospital Auckland, New Zealand Christchurch Hospital Christchurch, New Zealand 收起 <<
NCT00661895	Hypertension	Phase 4	Completed	-	United States, Nebraska ... 展开 >> Creighton Community Health Center Omaha, Nebraska, United States, 68104 收起 <<
NCT00283686	-		Completed	-	-
NCT00512759	Acute Heart Failure	Phase 4	Active, not recruiting	December 2019	Brazil ... 展开 >> Hospital Sao Paolo São Paulo, Brazil, 04024-002 Bulgaria 5-th Multifunctional Hospital for Active Treatment Sofia, Bulgaria National Transport Hospital "Tsar Boris III" Sofia, Bulgaria University Hospital "Tsaritsa Joanna-ISUL" Sofia, Bulgaria Germany University Hospital Mainz Mainz, Germany, 55131 Nuremberg Hospital Nuremberg, Germany, 90419 Spain Hospital Universitari Germans Trias i Pujol Badalona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08041 Switzerland University Hospital Basel Basel, BS, Switzerland, 4031 Kantonsspital Aarau Aarau, Switzerland, 5001 Kantonsspital Luzern Luzern, Switzerland, 6000 Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 收起 <<
NCT02592499	End-stage Heart Failure	Not Applicable	Recruiting	December 2022	Sweden ... 展开 >> Sahlgrenska Univesitetssjukhustet, Transplantationscentrum Recruiting Gothenburg, Sweden, 41234 Contact: Göran Dellgren +46 31-342 88 63 goran.dellgren@vgregion.se Linköping Univ Hospital Recruiting Linköping, Sweden Contact: Peter Wodlin, MD Skåne University Hospital Recruiting Lund, Sweden Contact: Oscar Braun, MD Karolinska Univ Hospital Recruiting Stockholm, Sweden Contact: Lars Lund, MD Univ Hospital of Umeå Recruiting Umeå, Sweden Contact: Krister Lindmark, MD Uppsala Univ Hospital Recruiting Uppsala, Sweden Contact: Ola Vedin, MD Örebro Univ Hospital Recruiting Örebro, Sweden Contact: Barna Szado, MD 收起 <<
NCT03616730	-		Not yet recruiting	December 30, 2020	-
NCT03147092	Hypertension ... 展开 >>Blood Pressure 收起 <<	Early Phase 1	Not yet recruiting	June 30, 2021	-
NCT00716079	Intracerebral Hemorrhage ... 展开 >> Stroke Hypertension 收起 <<	Not Applicable	Completed	-	-
NCT00716079	-		Completed	-	-
NCT00952081	Hypertension ... 展开 >>Brain Tumor Epilepsy 收起 <<	Phase 4	Completed	-	United States, New York ... 展开 >> NYU Langone Medical Center, Department of Anesthesiology New York, New York, United States, 10016 收起 <<
NCT00952081	-		Completed	-	-
NCT00684489	Hypertension	Not Applicable	Completed	-	-
NCT01422616	Ischemic Stroke ... 展开 >> High Blood Pressure 收起 <<	Phase 3	Recruiting	February 2019	Australia, New South Wales ... 展开 >> Royal Prince Alfred Hospital Recruiting Sydney, New South Wales, Australia, 2050 Contact: Craig S Anderson, MD +61 2 933 4500 canderson@georgeinstitute.org.au 收起 <<
NCT02620384	Acute Decompensated Heart Fail... 展开 >>ure 收起 <<	Phase 3	Completed	-	United States, Ohio ... 展开 >> Aultman Health Foundation Canton, Ohio, United States, 44710 收起 <<
NCT00000499	Cardiovascular Diseases ... 展开 >> Heart Diseases Hypertension Vascular Diseases 收起 <<	Phase 2	Completed	-	-
NCT02305095	-		Recruiting	June 2019	-
NCT03168529	Heart Failure	Phase 4	Recruiting	June 30, 2020	United States, Michigan ... 展开 >> Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Phillip D Levy, MD, MPH 313-577-1214 plevy@med.wayne.edu Contact: Patrick Medado 3137454621 pbmedado@med.wayne.edu Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact: David E Lanfear, MD, MS 313-916-5620 DLANFEA1@hfhs.org Contact: Karen Leszczynski, RN 3139163502 Kleszcz2@hfhs.org 收起 <<
NCT00223717	Hypertension	Phase 1	Completed	-	United States, Tennessee ... 展开 >> Vanderbilt University Nashville, Tennessee, United States, 37232 收起 <<
NCT00599235	Hypertension	Not Applicable	Completed	-	United Kingdom ... 展开 >> University of Edinburgh - Western General Hospital Edinburgh, United Kingdom, EH4 2XU 收起 <<
NCT01041963	Continuous Ambulatory Peritone... 展开 >>al Dialysis 收起 <<	Phase 4	Unknown	September 2010	Thailand ... 展开 >> Chulalongkorn university Recruiting Bangkok, Thailand, 10330 Contact: Talerngsak Kanjanabuch, Assist. Prf. 662-256-4321 ext 211 golfnephro@yahoo.com Principal Investigator: Talerngsak Kanjanabuch, Assist. Prf. Sub-Investigator: Wassawon Wontanatawatot, MD 收起 <<
NCT01255475	Heart Failure ... 展开 >> Cardiac Failure Congestive Heart Failure 收起 <<	Phase 2 Phase 3	Completed	-	Brazil ... 展开 >> Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, SP, Brazil, 05403000 收起 <<
NCT00772499	Hypertension	Phase 4	Completed	-	United States, North Carolina ... 展开 >> Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 收起 <<
NCT02446652	Cervical Cancer	Phase 3	Unknown	August 2018	Mexico ... 展开 >> National Institute of Cancerology Not yet recruiting Mexico City, DF, Mexico, 14080 Contact: Lucely Cetina, MD, MSc +52 555 628 0400 ext 56101 micuentalucely@yahoo.com 收起 <<
NCT02522208	Heart Failure	Phase 1	Completed	-	United States, Alabama ... 展开 >> Pinnacle Research Group, LLC Anniston, Alabama, United States, 36207 United States, Florida Linfritz Research Institue Inc Coral Gables, Florida, United States, 33134 Jacksonville Center for Clinical Research Jacksonville, Florida, United States, 32216 United States, Georgia Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Rhode Island Center for Medical Research, LLC Providence, Rhode Island, United States, 02908 收起 <<
NCT00204984	High Blood Pressure	Not Applicable	Completed	-	United States, Wisconsin ... 展开 >> University of Wisconsin Hospital & Clinics Madison, Wisconsin, United States, 53792 收起 <<
NCT01248169	-		Completed	-	United States, Mississippi ... 展开 >> Wiser Hospital for Women and Infants at the University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 收起 <<
NCT02281838	Intracerebral Hemorrhage	Phase 2	Recruiting	-	Canada, Alberta ... 展开 >> University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Ken S Butcher, MD, PhD 7804072171 ken.butcher@ualberta.ca Principal Investigator: Ken S Butcher, MD, PhD Canada, Ontario Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1Y 4E9 Contact: Dar Dowlatshahi 613-761-4709 ddowlat@toh.on.ca Principal Investigator: Dar Dowlatshahi, MD 收起 <<
NCT02046395	Type 2 Diabetes ... 展开 >> Hypertension 收起 <<	Phase 4	Recruiting	December 2019	United States, Louisiana ... 展开 >> Tulane University Health Sciences Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Bonnie L Katalenich, MPH 504-988-0200 bkatalen@tulane.edu Principal Investigator: Tina Thethi, MD, MPH 收起 <<
NCT00963976	Intracerebral Hemorrhage	Phase 2	Completed	-	Canada, Alberta ... 展开 >> University of Calgary Calgary, Alberta, Canada University of Alberta Edmonton, Alberta, Canada, T6G2B7 Grey Nuns Hospital Edmonton, Alberta, Canada, T6L 5X8 Canada, Ontario University of Ottawa Ottawa, Ontario, Canada 收起 <<
NCT02933593	Hypertension	Not Applicable	Withdrawn(PI withdrew the prot... 展开 >>ocol) 收起 <<	-	-
NCT00607477	Treatment Induced Hypertension	Not Applicable	Terminated(Study has been term... 展开 >>inated due to poor accrual.) 收起 <<	-	United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 收起 <<
NCT01587313	Healthy	Phase 1	Completed	-	United States, New Jersey ... 展开 >> Frontage Cinical Services Hackensack, New Jersey, United States, 07601 收起 <<
NCT01516346	Heart Failure ... 展开 >> Congestive Heart Failure 收起 <<	Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Philadelphia VA Medical Center Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT03514108	Heart Failure ... 展开 >> Diabetes 收起 <<	Phase 4	Recruiting	September 1, 2023	Denmark ... 展开 >> Sygehus Sønderjylland, Aabenraa Not yet recruiting Aabenraa, Denmark Contact: Bartlomiej Jonczy Aalborg University Hospital Not yet recruiting Aalborg, Denmark Contact: Søren Vraa Aarhus University Hospital Recruiting Aarhus, Denmark Contact: Henrik Wiggers +45 40136627 henrikwiggers@dadlnet.dk Sub-Investigator: Anders Jorsal Amager Hospital Not yet recruiting Copenhagen, Denmark Contact: Margrethe Ege Olsen Bispebjerg Hospital Not yet recruiting Copenhagen, Denmark Contact: Olav Wendelbo Nielsen Gentofte Hospital Recruiting Copenhagen, Denmark Contact: Morten Schou Glostrup Hospital Not yet recruiting Copenhagen, Denmark Contact: Morten Petersen Herlev Hospital Recruiting Copenhagen, Denmark Contact: Morten Schou Hvidovre Hospital Not yet recruiting Copenhagen, Denmark Contact: Jens Hove Rigshospitalet Recruiting Copenhagen, Denmark Contact: Lars Køber Principal Investigator: Finn Gustafsson Sydvestjysk Sygehus, Esbjerg Not yet recruiting Esbjerg, Denmark Contact: Kirsten Vilain Mikkelsen Herning Hospital Not yet recruiting Herning, Denmark Contact: Morten Bøttcher Regionshospital Nordjylland, Hjørring Not yet recruiting Hjørring, Denmark Contact: Gitte Nielsen Holbæk Hospital Not yet recruiting Holbæk, Denmark Contact: Ilan Raymond Horsens Hospital Not yet recruiting Horsens, Denmark Contact: Karen Kaae Dodt Kolding Hospital Not yet recruiting Kolding, Denmark Contact: Monica Petronela Poenaru Nykøbing Falster Hospital Not yet recruiting Nykøbing Falster, Denmark Contact: Lisbeth Tingsted Odense University Hospital Not yet recruiting Odense, Denmark Contact: Mikael Kjær Poulsen Sjællands Universitetshospital, Roskilde Not yet recruiting Roskilde, Denmark Contact: Nina Pernille Gardshodn Buch Silkeborg Hospital Not yet recruiting Silkeborg, Denmark Contact: Anne Sejr Knudsen Slagelse Sygehus Not yet recruiting Slagelse, Denmark Contact: Henrik Ryde Vejle Hospital Not yet recruiting Vejle, Denmark Contact: Vibeke Brogaard Viborg Hospital Not yet recruiting Viborg, Denmark Contact: Anne Pauline Schrøder 收起 <<
NCT01356875	Myelodysplastic Syndrome	Phase 2	Unknown	January 2015	Spain ... 展开 >> Txagorritxu Hospital Not yet recruiting Vitoria-Gasteiz, Alava, Spain, 01009 Contact: Breno Moreno de Gusmao, MD +34 945 007000 breno.morenodegusmao@osakidetza.net 收起 <<
NCT00607477	-		Terminated(Study has been term... 展开 >>inated due to poor accrual.) 收起 <<	-	-
NCT00575640	Rectal Cancer	Phase 1 Phase 2	Withdrawn(No enrollment)	-	-
NCT00404326	Cervical Cancer	Phase 2	Completed	-	Mexico ... 展开 >> National Institute of Cancerologia Mexico City, Tlalpan, Mexico, 14080 收起 <<
NCT00532818	Metastatic Cervical Cancer	Phase 3	Unknown	December 2010	Mexico ... 展开 >> Instituto Nacional de Cancerologia Recruiting Mexico City, Distrito Federal, Mexico, 14080 Principal Investigator: Lucely Cetina, MD 收起 <<
NCT02343393	Cardio-Renal Syndrome	Phase 3	Unknown	June 2016	Singapore ... 展开 >> National University Hospital, Singapore Recruiting Singapore, Singapore, 119228 Contact: Shir Lynn Lim, MBBS, MRCP, MMed shir_lynn_lim@nuhs.edu.sg Principal Investigator: Shir Lynn Lim, MBBS, MRCP, MMed National Heart Centre Singapore Not yet recruiting Singapore, Singapore, 169609 Contact: Kheng Leng David Sim, MBBS, MRCP, MS david_sim@nhcs.com.sg Principal Investigator: Kheng Leng David Sim, MBBS, MRCP, MS Changi General Hospital Not yet recruiting Singapore, Singapore, 529889 Contact: Kui Toh Gerard Leong, MBBS, MRCP, MS gerard_leong@cgh.com.sg Principal Investigator: Kui Toh Gerard Leong, MBBS, MRCP, MS 收起 <<
NCT00395655	Locally Advanced Breast Cancer	Phase 2	Terminated	-	Mexico ... 展开 >> Instituto Nacional de Cancerologia Mexico City, Tlalpan, Mexico, 14080 收起 <<
NCT00404508	Refractory Solid Tumors	Phase 2	Completed	-	Mexico ... 展开 >> National Institute of Cancerologia Mexico City, Tlalpan, Mexico, 14080 收起 <<
NCT01538875	Hypertension, Pregnancy Induce... 展开 >>d 收起 <<	Phase 3	Completed	-	Panama ... 展开 >> Saint Thomas Maternity Hospital Panama, Panama 收起 <<
NCT03423810	Polycystic Kidney Diseases	Early Phase 1	Recruiting	May 15, 2019	United States, Kansas ... 展开 >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 收起 <<
NCT00996060	Lung Cancer	Phase 1	Completed	-	United States, New Mexico ... 展开 >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 收起 <<
NCT02228408	Chronic Hemodialysis (ESRD)	Phase 4	Recruiting	December 15, 2020	United States, Massachusetts ... 展开 >> Brigham & Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: David Charytan, MD 收起 <<
NCT00575978	Breast Cancer	Phase 1 Phase 2	Withdrawn(IRB request)	December 2009	-
NCT02050529	Hypertension, Pregnancy Induce... 展开 >>d Hydralazine Adverse Reaction Pre-eclampsia Pre-eclampsia Superimposed Pre-existing Hypertension 收起 <<	Phase 2	Completed	-	Pakistan ... 展开 >> Civil Hospital Karachi Karachi, Sindh, Pakistan, 74200 收起 <<
NCT01822808	Acute Heart Failure ... 展开 >> Left Ventricular Dysfunction 收起 <<	Phase 3	Unknown	July 2016	South Africa ... 展开 >> Hatter Institute for Cardiovascular Research in Africa Cape Town, Western Cape, South Africa, 7925 收起 <<
NCT00533299	Ovarian Cancer	Phase 3	Unknown	December 2009	Mexico ... 展开 >> Instituto Nacional de Cancerologia Recruiting Mexico City, Tlalpan, Mexico, 14080 Principal Investigator: Dolores Gallardo, MD 收起 <<

盐酸肼屈嗪 /Hydralazine HCl {[allProObj[0].p_purity_real_show]}

Hydralazine HCl 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Hydralazine HCl 质控信息

Hydralazine HCl 生物活性

Hydralazine HCl 临床研究

Hydralazine HCl 参考文献

Hydralazine HCl 实验方案

Hydralazine HCl 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

盐酸肼屈嗪 /Hydralazine HCl {[allProObj[0].p_purity_real_show]}

Hydralazine HCl 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Hydralazine HCl 质控信息

Hydralazine HCl 生物活性

Hydralazine HCl 临床研究

Hydralazine HCl 参考文献

Hydralazine HCl 实验方案

Hydralazine HCl 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Hydralazine HCl 纯度/质量文件产品仅供科研